HIV 2012 - Eleventh International Congress on Drug Therapy in HIV Infection

Abstract Categories for 2012
Adherence
Adverse Events:
Cardiovascular
Metabolic
Renal
Hepatic
Mitochondrial toxicity
Bone
Other
Clinical Pharmacology
Community Initiatives
Cost-effectiveness
Evaluation of ARV Delivery and Coverage
HIV-related Infections, Co-infections and Cancers, etc:
Opportunistic infections
Tuberculosis
Hepatitis co-infection (HCV and HBV)
Cancers
Other
Laboratory Monitoring of Disease and Therapy
Mother-to-child Transmission
New Treatments and Targets
Non-AIDS Morbidities and Mortality, and Ageing
Pre- and Post-Exposure Prophylaxis and Treatment as Prevention
Resistance
Treatment of Children
Treatment Strategies:
Treatment of primary infection
Naïve patients
Experienced patients
Heavily pre-treated patients
Switch studies
Simplification
Other
Late Breaker Abstracts
Anyone wishing to submit a late breaker abstract should send a letter of intent to: hiv11-AT-kp360group.com by the regular abstract deadline of Monday 16 July addressed to Professor Ian Weller, Chairperson. Only those individuals who have submitted this information and had confirmation of receipt from the Secretariat are permitted to follow with a late-breaker abstract submission. The deadline for the late breaker abstract is Monday 13 August.